Kung Winston 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Corbus (CRBP) Director Winston Kung Sells 2,026 Shares
What Happened Winston Kung, a director of Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 2,026 shares on June 10, 2026. The Form 4 reports a weighted average sale price of $7.91 for aggregate proceeds of approximately $16,033. The sale was reported as an open market/private sale (Code S).
Key Details
- Transaction date: 2026-06-10; Form filed: 2026-06-11 (timely).
- Price: weighted average $7.91; underlying trade prices ranged $7.71–$7.97. Reporting person can provide per-price breakdown on request (Footnote F2).
- Proceeds: ~$16,033 for 2,026 shares sold.
- Plan/authorization: transaction effected pursuant to a Rule 10b5-1 trading plan adopted March 11, 2026 (Footnote F1).
- Holdings note: the reported ownership figure in the filing includes 3,800 unvested RSUs subject to vesting (Footnote F3).
- Filing accession: SEC Filing 0001193125-26-267672.
Context Sales executed under a 10b5-1 plan are pre-arranged and often scheduled in advance, which can limit what the sale implies about the insider’s view. This was a modest single sale by a director; retail investors should consider it as one data point and review the full Form 4 for additional ownership details.
Insider Transaction Report
- Sale
Common Stock, par value $0.0001 per share
[F1][F2][F3]2026-06-10$7.91/sh−2,026$16,033→ 12,140 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported.